Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1

Virology

Volumn 243, Issue 2, 1998, Pages 313-321

  Lechner, Sabine ^a   Rispeter, Kay ^a   Meisel, Helga ^b   Kraas, Wolfgang ^c   Jung, Günther ^c   Roggendorf, Michael ^a   Zibert, Andree ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c Institut für Organische Chemie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN;

ANTIBODY DETECTION; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS HEPATITIS; VIRUS INFECTION;

HEPATITIS C VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 0032502645     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9069     Document Type: Article

References (46)

1. Allander T., Beyene A., Jacobson S. H., Grillner L., Persson M. A. Patients infected with the same hepatitis c virus strain display different kinetics of the isolate-specific antibody response. J. Infect. Dis. 175:1997;26-31.
2. Alter H. J., Purcell R. H., Shih J. W. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 321:1989;1494-1500.
3. Alter M. J. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C. Arch. Pathol. Lab. Med. 118:1994;342-345.
4. Alter M. J., Margolis H. S., Krawczynski K. The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327:1992;1899-1905.
5. Bukh J., Miller R. H., Purcell R. H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15:1995;41-63.
6. Chien D. Y., Choo Q. L., Ralston R., Spaete R., Tong M., Houghton M., Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet. 342:1993;933.
7. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science. 244:1989;359-362.
8. Choo Q. L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 91:1994;1294-1298.
9. Dittmann S., Roggendorf M., Durkop J., Wiese M., Lorbeer B., Deinhardt F. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J. Hepatol. 13:1991;323-327.
10. Dubuisson J., Hsu H. H., Cheung R. C., Greenberg H. B., Russell D. G., Rice C. M. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 68:1994;6147-6160.
11. Farci P., Alter H. J., Govindarajan S., Wong D. C., Engle R., Lesniewski R. R., Mushahwar I. K., Desai S. M., Miller R. H., Ogata N. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992;135-140.
12. Farci P., Alter H. J., Wong D. C., Miller R. H., Govindarajan S., Engle R., Shapiro M., Purcell R. H. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA. 91:1994;7792-7796.
13. Farci P., Shimoda A., Wang D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y. K., Shapiro M., Alter H. J., Purcell R. H. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 proteins. Proc. Natl. Acad. Sci. USA. 93:1996;15394-15399.
14. Guan K. L., Dixon J. E. Eukaryotic proteins expressed inEscherichia coli: Anal. Biochem. 192:1991;262-267.
15. Hada H., Koide N., Hanafusa T., Sakaguchi K., Shinji T., Sasaki S., Oka T., Takayama N., Yumoto Y., Tsuji T. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease. Acta Med. Okayama. 46:1992;365-370.
16. Harada S., Suzuki R., Ando A., Watanabe Y., Yagi S., Miyamura T., Saito I. Establishment of a cell line constitutively expressing E2 glycoproteins of hepatitis C virus and humoral response of hepatitis C patients to the expressed protein. J. Gen. Virol. 76:1995;1223-1231.
17. Higashi Y., Kakumu S., Yoshioka K., Wakita T., Mizokami M., Ohba K., Ito Y., Ishikawa T., Takayanagi M., Nagai Y. Dynamics of genome change in the E2/NS1 region of hepatitis C virusin vivo. Virology. 197:1993;659-668.
18. Hohne M., Schreier E., Roggendorf M. Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch. Virol. 137:1994;25-34.
19. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;9524-9528.
20. Kato N., Ootsuyama Y., Sekiya H., Ohkoshi S., Nakazawa T., Hijikata M., Shimotohno K. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J. Virol. 68:1994;4776-4784.
21. Kojima M., Osuga T., Tsuda F., Tanaka T., Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology. 204:1994;665-672.
22. Kraas W., Ihlenfeldt H. G., Seidel C., Wienhus U., Schmitt U., Jung G. Peptides 1994. 1995;. p. 827-828.
23. Kurosaki M., Enomoto N., Marumo F., Sato C. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virology. 205:1994;161-169.
24. Lanford R. E., Notvall L., Chavez D., White R., Frenzel G., Simonsen C., Kim J. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology. 197:1993;225-235.
25. Lesniewski R., Okasinski G., Carrick R., Van Sant C., Desai S., Johnson R., Scheffel J., Moore B., Mushahwar I. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia. J. Med. Virol. 45:1995;415-422.
26. Marston F. A. Glover D. M. DNA Cloning: A Practical Approach. 1987;59-79 IRL Press, Oxford.
27. Martell M., Esteban J. I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J. Virol. 66:1992;3225-3229.
28. Mita E., Hayashi N., Ueda K., Kasahara A., Fusamoto H., Takamizawa A., Matsubara K., Okayama H., Kamada T. Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease. Biochem. Biophys. Res. Commun. 183:1992;925-930.
29. Miyamura T., Saito I., Katayama T., Kikuchi S., Tateda A., Houghton M., Choo Q. L., Kuo G. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for post transfusion hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;983-987.
30. Moss B., Elroy-Stein O., Mizukami T., Fuerst T. R. New mammalian expression vectors. Nature. 348:1990;91-93.
31. Ray R., Khanna A., Lagging L. M., Meyer K., Choo Q. L., Ralston R., Houghton M., Becherer P. R. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J. Virol. 68:1994;4420-4426.
32. Rosa D., Campagnoli S., Moretto C., Guenzi E., Cousens L., Chin M., Dong C., Weiner A., Lau J. Y., Choo Q. L., Chien D., Pileri P., Houghton M., Abrignani S. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA. 93:1996;1759-1763.
33. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
34. Saracco G., Abate M. L., Baldi M., Calvo P. L., Manzini P., Brunetto M. R., Oliveri F., Kuo G., Chien D., Houghton M. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver. 14:1994;65-70.
35. Sattentau Q. J., Moore J. P. HIV-1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:1995;185-196.
36. Scarselli E., Cerino A., Esposito G., Silini E., Mondelli M., Traboni C. Occurence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J. Virol. 69:1995;4407-4412.
37. Shimizu Y. K., Hijikata M., Iwamoto A., Alter H. J., Purcell R. H., Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68:1994;1494-1500.
38. Taniguchi S., Okamoto H., Sakamoto M., Kojima M., Tsuda F., Tanaka T., Munekata E., Muchmore E. E., Peterson D. A., Mishiro S. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: Implication for an escape from antibody. Virology. 195:1993;297-301.
39. van Doorn L. J., Capriles I., Maertens G., DeLeys R., Murray K., Kos T., Schellekens H., Quint W. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J. Virol. 69:1995;773-778.
40. Weiner A. J., Erickson A. L., Kansopon J., Crawford K., Muchmore E., Hughes A. L., Houghton M., Walker C. M. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA. 92:1995;2755-2759.
41. Weiner A. J., Brauer M. J., Rosenblatt J., Richman K. H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q. L., Houghton M. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology. 180:1991;842-848.
42. Yan B. S., Liao L. Y., Leou K., Chang Y. C., Syu W. J. Truncating the putative membrane association region circumvents the difficulty of expressing hepatitis C virus protein E1 inEscherichia coli. J. Virol. Methods. 49:1994;343-351.
43. Yuki N., Hayashi N., Kasahara A., Hagiwara H., Mita E., Ohkawa K., Katayama K., Fusamoto H., Kamada T. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology. 23:1996;947-952.
44. Zibert A., Schreier E., Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology. 208:1995;653-661.
45. Zibert A., Kraas W., Meisel H., Jung G., Roggendorf M. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infection of hepatitis C virus. J. Virol. 71:1997a;4123-4127.
46. Zibert A., Meisel H., Kraas W., Schulz A., Jung G., Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology. 25:1997b;1045-1049.